Allow Medicare to negotiate drug prices with pharmaceutical companies.

Morgan McGarvey · Kentucky · Democratic

policy impact 0.78 specificity 0.88 extraction confidence 98%

Occurrences

We must allow Medicare to negotiate drug prices with pharmaceutical companies.

The candidate commits to enabling Medicare drug-price negotiation.

Morgan McGarvey on Health Care
campaign · campaign_site · model gpt-5.4-mini

Evidence

“We must allow Medicare to negotiate drug prices with pharmaceutical companies.”

McGarvey’s campaign site explicitly endorsed Medicare drug-price negotiation, establishing the promise/policy position he was running on.

unresolved unknown

Morgan McGarvey on Health Care
campaign · model gpt-5.4-mini · confidence 96%

The IRA creates a new Drug Price Negotiation Program requiring the Secretary of HHS to negotiate prices for certain qualifying single-source drugs furnished to Medicare beneficiaries.

Official CRS material confirms that Medicare drug-price negotiation was enacted in the Inflation Reduction Act, meaning the policy itself was delivered nationally before McGarvey’s current term began.

delivered same_term

Selected Issues in Pharmaceutical Drug Pricing
secondary · model gpt-5.4-mini · confidence 94%

Sponsor: Rep. McGarvey, Morgan [D-KY-3] (Introduced 06/25/2025). This bill eliminates cost-sharing for generic drugs for those with the lowest-income under the Medicare prescription drug benefit's Low-Income Subsidy Program beginning in 2026.

McGarvey later introduced a Medicare drug-cost bill, which shows follow-on effort on prescription affordability, but it does not itself enact Medicare drug-price negotiation.

partial same_term A for effort

H.R.4139 - 119th Congress (2025-2026): Cutting Copays Act | Congress.gov | Library of Congress
primary · model gpt-5.4-mini · confidence 78%

Assessments

partial unknown

Medicare drug-price negotiation was enacted nationally through the Inflation Reduction Act in 2022, before Morgan McGarvey entered Congress in January 2023 and before the cited 2024 campaign promise. Because the promised policy outcome existed, but was completed by other federal officials with no shown McGarvey contribution, this should not be credited as fully delivered by him. His later Cutting Copays Act shows related prescription-drug affordability effort, but it did not enact or materially advance Medicare negotiation authority.

provider codex_cli · model gpt-5.5 · confidence 90%

delivered unknown

The promised policy outcome, allowing Medicare to negotiate drug prices with pharmaceutical companies, was enacted nationally through the Inflation Reduction Act's Medicare Drug Price Negotiation Program before McGarvey's current congressional service. McGarvey later introduced related drug-affordability legislation, but that bill addressed generic drug cost-sharing rather than creating or expanding Medicare negotiation authority. Because the core promised outcome exists in federal law, the promise is best rated delivered, though the timing is not attributable to his same or later term.

provider codex_cli · model gpt-5.5 · confidence 86%